New avenues in mild moderate UC treatment optimization

Growing evidence indicates that ulcerative colitis (UC) is a progressive disease. For this reason, early treatment based on the treat-to-target (T2T) strategy could avoid complications and ensure optimal disease control. We intend to organize a live webinar to discuss the latest data and approaches towards treatment optimization.

This will include presentation by the Principal Investigators of the results and clinical implications of the OPTIMISE study – the first T2T study in mild-to-moderate UC.